Recovery of Cytopathogenic Agent from Chimpanzees with Goryza

  title={Recovery of Cytopathogenic Agent from Chimpanzees with Goryza},
  author={J. Anthony Morris and R. E. Peppy Blount and Robert E. Savage},
  journal={Proceedings of the Society for Experimental Biology and Medicine},
  pages={544 - 549}
Summary A virus was recovered from throat materials of a chimpanzee with coryza during an epizootic of respiratory disease in a colony of these animals. The new agent produced degenerative changes in tissue culture, but was not pathogenic for common laboratory animals. The donor chimpanzee as well as other chimpanzees involved in the epizootic developed specific antibodies against the coryza agent during the months following the outbreak. Susceptible chimpanzees following intranasal… 

Figures and Tables from this paper

Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization.
The present study was undertaken in an attempt to recover new cytopathogenic agents from infants with severe lower respiratory illness and to assess their etiologic significance in this disease complex.
Respiratory syncytial virus infection in the north west of England
The laboratory methods used in diagnosing fifty-four infections with R. S. virus in this area during the period December, 1961 to April, 1962, are described and consisted of either virus isolation or the demonstration of a rise in specific antibody.
Neutralisation of respiratory syncytial virus by cat serum
It is shown that antibody to RS virus is widespread in domestic cats in Britain, and this observation was based on an observation that the sera of some laboratory cats in the USA inhibited RS virus.
Bovine respiratory syncytial virus: Host range in laboratory animals and cell cultures
The host range of the bovine RS virus, strain NMK7, recovered from a diseased cow during the 1968/69 outbreak in Japan was examined both in experimental animals and cell cultures, and the simultaneously tested human RS virus exhibited a smaller host cell range in cultures of animal provenance and showed optimal growth in human cells.
Studies of acute respiratory illnesses caused by respiratory syncytial virus. 3. Clinical and laboratory findings.
The respiratory syncytial virus, initially designated chimpanzee-coryza agent (CCA), was first recovered by Morris et al. from chimpanzees with respiratory illness and from a laboratory worker.
Epidemiological study of zoonoses derived from humans in captive chimpanzees
Results suggest that the proportions of human-borne infections may reflect the chimpanzee’s history, management system in the institute, or regional epidemics, and captive chimpanzees are highly susceptible to human pathogens, and their induced antibodies reveal not only their history of infection, but also the possibility of protection against human pathogens.
Respiratory Syncytial Virus Infections in Families
  • B. Berglund
  • Biology, Medicine
    Acta paediatrica Scandinavica
  • 1967
A comparatively limited number of studies have been concerned with the incidence of RS virus infections in adults, and some of these studies will be surveyed here.
Paramyxoviruses infecting humans: the old, the new and the unknown.
The current body of scientific knowledge, disease burden and knowledge of reservoirs of these emerging paramyxoviruses is explored and a comparative review of both older and emerging viruses that have been shown to infect humans is provided.
Experimental respiratory syncytial virus infection of four species of primates
Four species of nonhuman primates were inoculated intranasally with respiratory syncytial virus and chimpanzees are proposed as a possible animal model for future study of the immunopathology of RS virus desease and for in vivo evaluation of attendated live virus vaccine candidates.